Search Results - "Sabato, Philip E"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection by Nicol, Melanie R., Joshi, Abhay, Rizk, Matthew L., Sabato, Philip E., Savic, Radojka M., Wesche, David, Zheng, Jenny H., Cook, Jack

    Published in Clinical pharmacology and therapeutics (01-12-2020)
    “…Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria. To date, these medications are not approved for the treatment of viral…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Discovery of Methyl 4′-Methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate, an Improved Small-Molecule Inhibitor of c-Myc-Max Dimerization by Chauhan, Jay, Wang, Huabo, Yap, Jeremy L., Sabato, Philip E., Hu, Angela, Prochownik, Edward V., Fletcher, Steven

    Published in ChemMedChem (01-10-2014)
    “…c‐Myc is a basic helix‐loop‐helix‐leucine zipper (bHLH‐ZIP) transcription factor that is responsible for the transcription of a wide range of target genes…”
    Get full text
    Journal Article
  4. 4

    Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5 by Wang, Huabo, Chauhan, Jay, Hu, Angela, Pendleton, Kelsey, Yap, Jeremy L, Sabato, Philip E, Jones, Jace W, Perri, Mariarita, Yu, Jianshi, Cione, Erika, Kane, Maureen A, Fletcher, Steven, Prochownik, Edward V

    Published in Oncotarget (01-06-2013)
    “…The c-Myc (Myc) oncoprotein is a high-value therapeutic target given that it is deregulated in multiple types of cancer. However, potent small molecule…”
    Get full text
    Journal Article
  5. 5
  6. 6

    590. Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model by Avery, Lindsay M, Edwards, Mitchell, Yi, Fan, Sabato, Philip E, Moeck, Greg, Pevear, Daniel C

    Published in Open forum infectious diseases (15-12-2022)
    “…Abstract Background Cefepime-taniborbactam (FTB) combines cefepime (FEP), a fourth generation cephalosporin with taniborbactam, a novel inhibitor of metallo…”
    Get full text
    Journal Article